| Target Price | ¥2,499.00 |
| Price | ¥2,442.00 |
| Potential |
2.33%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Ono Pharmaceutical 2027 .
The average Ono Pharmaceutical target price is ¥2,499.00.
This is
2.33%
register free of charge
¥3,360.00
37.59%
register free of charge
¥2,070.50
15.21%
register free of charge
|
|
| A rating was issued by 20 analysts: 3 Analysts recommend Ono Pharmaceutical to buy, 10 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2027 of
2.33%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 515.79 | 462.73 |
| 5.94% | 10.29% | |
| EBITDA Margin | 18.48% | 29.51% |
| 38.63% | 59.68% | |
| Net Margin | 13.53% | 17.00% |
| 31.59% | 25.68% |
15 Analysts have issued a sales forecast Ono Pharmaceutical 2027 . The average Ono Pharmaceutical sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2027. The average Ono Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Ono Pharmaceutical Analysts have issued a net profit forecast 2027. The average Ono Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 148.48 | 167.40 |
| 39.38% | 12.74% | |
| P/E | 14.38 | |
| EV/Sales | 2.20 |
15 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Ono Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


